Attached files
| file | filename |
|---|---|
| 8-K - 8-K - Nabriva Therapeutics plc | a17-14242_18k.htm |
Exhibit 16.1
|
|
|
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
|
May 31, 2017 |
|
Commissioners:
We have read the statements made by Nabriva Therapeutics AG (copy attached), which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 4.01 of Form 8-K, as part of the Form 8-K of Nabriva Therapeutics AG dated May 31, 2017. We agree with the statements concerning our Firm in such Form 8-K.
|
Very truly yours, |
|
|
|
|
|
/s/ Alexandra Rester |
|
|
Austrian Certified Public Accountant |
|
|
|
|
|
PwC Wirtschaftsprüfung GmbH |
|
|
Erdbergstrasse 200, 1030 Vienna, |
|
|
Austria |
|